US biopharma: "nearly 300 vaccines in R&D"

Article Date: 24/04/2012 06:00
US biopharma: "nearly 300 vaccines in R&D"

Vacancy Search

Quick job search

Advanced Search

Latest News

Zimmer and Biomet hook up for second orthopaedics megamerger

And they said it could not happen. Zimmer’s $13.4bn purchase of Biomet will be the fourth-biggest deal in the history of medtech, and it is in an area that is already heavily consolidated:...

Allergan deploys 'poison pill' defence on Valeant bid

Allergan deploys 'poison pill' defence on Valeant bid

Janssen's Sylvant wins FDA nod for rare blood disorder

Janssen's Sylvant wins FDA nod for rare blood disorder

Patients hail "fantastic news" as NICE backs Velcade

Patients hail "fantastic news" as NICE backs Velcade

Soliris gets orphan status for organ transplants

Soliris gets orphan status for organ transplants

Heat on Roche to cut Kadcyla price after NICE 'no'

Heat on Roche to cut Kadcyla price after NICE 'no'

AbbVie files hep C combo in the US

AbbVie files hep C combo in the US

US "urgently" needs new ways to incentivise pharma

US "urgently" needs new ways to incentivise pharma

Vietnam pharma market "to grow 20% to 2017"

Vietnam pharma market "to grow 20% to 2017"

Novartis 'transforms' itself with multi-billion-dollar GSK, Lilly deals

Novartis 'transforms' itself with multi-billion-dollar GSK, Lilly deals
more news